Precision Therapeutics, Forged by Evolution
Cutting-edge research aimed at improving treatment of GI diseases
Our Approach
Building Upon Nature
to Improve Global Health
Kissaki Biosciences is developing novel approaches
to treat gastrointestinal disorders, including:
- Gastric cancer
- Inflammatory bowel disease
- Diarrhea
Our innovative precision therapies are inspired by natural
products and primarily target gut dysbiosis.
Our Pipeline
Both in the U.S. and across the globe, infectious diarrhea (ID) continues to be a massive health concern, encompassing over 100 million cases each year, with a particular concentration in children. Nearly 500,000 of these yearly cases are sufficiently severe as to cause mortality.
Grave morbidity is also associated with these infections, resulting in growth impairment and cognitive decline, among other symptoms. Bacterial pathogens enterotoxigenic E. coli (ETEC) and enteroaggregative E. coli (EAEC) are among the major causative pathogens of ID. We have focused our mission on the elaboration and development of a family of gut-restricted, precision antibiotics.
Meet the Kissaki Team
Our team capitalizes on decades of drug development experience to
accelerate our treatments to and through the clinic.
About us
The Story & Purpose
Behind Our Name
Gorō Nyūdō Masamune was a medieval Japanese blacksmith
widely acclaimed as Japan’s greatest swordsmith.
In keeping with this tradition of excellence and innovation, we
chose the name Kissaki, which in Japanese, means the “tip of the
sword” or “cutting edge”. The hunt for cutting edge technologies
to treat human diseases is the core of our mission.
Get in Touch With Us
Fill out this form to contact Kissaki Biosciences